Plain-English translation of NCT06911632 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a new artificial intelligence tool that analyzes a simple heart electrical test (called an ECG) to spot people with interstitial lung disease who may have hidden high blood pressure in their lungs. The AI tool aims to help doctors catch this serious but often-missed condition earlier. By comparing results between people who receive the AI analysis and those who don't, the study will see if this approach leads to more accurate diagnoses.
High blood pressure in the lungs is a serious complication that many people with interstitial lung disease develop without knowing it, and it often goes undiagnosed for too long. This study exists to see whether an AI-powered heart scan can help doctors spot this hidden condition sooner, so people can get treatment before it becomes severe.
You likely qualify if…
You likely don't qualify if…
You will receive a standard heart electrical test (ECG) at the start. You'll then be randomly assigned to either receive or not receive the AI analysis results. If you're assigned to the analysis group and the AI identifies you as high risk, you'll receive two additional heart tests: an ultrasound of your heart and a more detailed heart catheterization procedure. The study lasts about 6 months, during which your regular doctors will continue to monitor your lung disease and make any additional medical decisions as needed.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
United States